BENDAMUSTINA ACTAVIS 2.5mg/ml powder for concentrate for solution for infusion
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Find medicines for human use by name or active substance.
Browse by initial
81–100 of 789 medicines
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: bendamustine
L01AA09 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Indicated for: hematologic malignancies
Active substance: bacitracin + neomycin
D06AX04 Dermatologicals | Antibiotics for topical use | Other antibiotics for topical use
Indicated for: bacterial infections
Active substance: nonacog alfa
B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: nonacog alfa
B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: nonacog alfa
B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: nonacog alfa
B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: nonacog alfa
B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: sodium chloride + potassium chloride + calcium chloride + magnesium chloride + sodium acetate + glucose
Indicated for: fluid and electrolyte replacement with carbohydrate supply
Active substance: etanercept
Indicated for: autoimmune inflammatory diseases
Active substance: etanercept
Indicated for: autoimmune inflammatory diseases
Active substance: etanercept
Indicated for: autoimmune inflammatory diseases
Active substance: benfotiamine
Indicated for: vitamin B1 deficiency
Active substance: benfotiamine
Indicated for: vitamin B1 deficiency
Active substance: benfotiamine
Indicated for: vitamin B1 deficiency
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.